Moreover, the association between albumin level and cancer has been extensively studied, in which a series of studies have found that albumin acts as a prognostic factor and can predict clinical outcomes of hepatocellular carcinoma [13], prostate cancer [14], acute myeloblastic leukemia [15], and GC [16]. This evidence concerns the gene ALB and Familial prostate cancer.